The Role of the Fujinon Intelligent Chromo Endoscopy (FICE™) in Barrett's Esophagus

Mayo Clinic50 enrolled

Overview

The purpose of this study to assess post ablation, if there are areas of Barrett's mucosa post ablation and to assess the ability of the Fujinon FICE system to detect this, as compared to white light endoscopy. A subgroup will also be compared with laser confocal microscopy

Study Type

OBSERVATIONAL

Enrollment

Conditions

Barrett's Esophagus

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Visible Barrett's esophagus * Scheduled for Surveillance Endoscopy * Able to undergo endoscopy Exclusion Criteria: * Unable to undergo endoscopy * Unable to stop blood thinning medications

Locations (1)

Mayo Clinic Rochester

Rochester, Minnesota, United States

Outcomes

Primary Outcomes

detection of dysplasic areas

Areas of residual mucosa will be scored for being present, absent or suspicious. The ability of both FICE and white light endoscopy to find areas will be graded on the number of areas found, and the size of the areas estimated at the time of endoscopy

Time frame: during surveillance endoscopy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.